Shaquille O'Neal, a four-time NBA champion, told CNBC that one of the game's greatest players inspires his business ventures.» Read More
Discussing today's market action, with Andres Garcia-Amaya, JPMorgan Funds; Robert Keiser, S&P Capital IQ; Brian Belski, BMO Capital Markets; and Mark Luschini, Janney Montgomery Scott.
When might the Fed taper QE? CNBC's Bob Pisani, Steve Liesman and Rick Santelli, discuss. "These programs have run their course," says Santelli.
General John Campbell, US Army, rang the closing bell today at the NYSE. He appears on Closing Bell to discuss the anniversary of the Army and the biggest challenges the military faces today, including the impact of sequestration on training and preparedness.
Robert Kraft, New England Patriots owner, discusses his team's signing of former Bronco and Jets quarterback, Tim Tebow. We want high quality people who work hard, says Kraft.
Greg Ip, U.S. Economics Editor, The Economist, and CNBC's Rick Santelli, look ahead to what Bernanke is likely to say next week following the Fed meeting.
Rich Peterson, Standard & Poor's Capital IQ, Ralph Acampora, Altaira Ltd. and Mark Spellman, Value Line Funds, discuss market volatility and whether we're still in a long, secular bull market.
Jeff Cox, CNBC.com, and David Sterman, Street Authority, discuss how to prepare your portfolio for the possibility of a rise in interest rates. Do rising rates mean an end to the rally?
Kenny Polcari, O'Neil Securities, and Tim Leach, U.S. Bank Wealth Management Group, discuss what's happening in the markets now and what the Fed is likely to do with tapering. With CNBC's Rick Santelli.
The Supreme Court ruled unanimously that human genes cannot be patented. CNBC's Maria Bartiromo shares her observation.
Smith & Wesson says it expects Q4 earnings and revenue to beat its previous expectations, and that its board has approved a repurchase of up to $100 million in stock, reports CNBC's Josh Lipton.
Looking ahead to Friday's trading day, with Jason Lilly, Rockland Trust Investment Group; Telly Zachariades, Valence Group Partner; and Anthem Blanchard, Anthem Vault CEO.
Discussing the concerns over the NSA surveillance program's impact on businesses, with Jonathan Pollet, Red Tiger Security, and David Walsh, Prescient Edge CEO.
Are $25 movie tickets in the future? Discussing trends in entertainment, with CNBC's Julia Boorstin; Paul Dergarabedian, Hollywood.com; and Grady Smith, Entertainment Weekly, discuss.
There was a 7 second early pop in July natural gas futures this morning before the economic data was released, reports CNBC's Eamon Javers. Kenny Polcari, O'Neil Securities; Thomas Curran, Peckar & Abramson; and CNBC's John Carney, discuss.
Discussing the global market action, with John Spallanzani, GFI Group, and John Nyarad, Wall Street Sector Selector Publisher.
Dissecting today's rally, with CNBC's Bob Pisani, Jeff Cox and Rick Santelli; Heather Hughes, SunAmerica Funds; and Doug Sandler, Riverfront Investment Group. "There is a lot of hope for the second half of the year that the economy will pick up where the Fed will leave off," says Cox.
Will it be a June swoon? Dissecting the fall in Japan and an increase in volatility in the markets, with Dan McMahon, Raymond James, and Mark Otto, Knight Capital.
Media mogul Rupert Murdoch is getting divorced from his wife Wendi Deng Murdoch. Sarah Ellison, Vanity Fair, and CNBC's Robert Frank discuss.
CNBC's Bertha Coombs reports shares of Myriad Genetics are hitting an all-time high after the Supreme Court ruled a naturally occurring human gene cannot be patented, but upheld key DNA patents of Myriad's BRACAnalysis test.
Is Lululemon worth an investment? Richard Ross, Auerbach Grayson, and Zachary Karabell, River Twice Research, share their opinions.